Strides Pharma Science informs about completion of inspection

06 Apr 2024 Evaluate

Strides Pharma Science has informed that a routine current Good Manufacturing Practices (cGMP) inspection was conducted by the United States Food and Drug Administration (USFDA) at the Formulations Facility of Strides Alathur, a wholly owned subsidiary of the Company, at Alathur, Chennai during the week of April 1, 2024 to April 5, 2024. The inspection closed with two observations. Company will respond to these observations comprehensively to FDA within the stipulated time.

The above information is a part of company’s filings submitted to BSE.

Strides Pharma Scien Share Price

654.15 -26.80 (-3.94%)
25-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.85
Dr. Reddys Lab 1173.55
Cipla 1525.50
Lupin 2018.35
Zydus Lifesciences 859.10
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...